Skip to main content
CallTapePositive Skew

Showing the saved snapshot

ANAB

Investors & research · 32 curated contributors. How we select contributors.

Blended score +20 (n = 1 contributor) · how it’s computed

Only one contributor in the curated list has called this ticker, so it is hidden from the home page by default.

Latest call by contributor

One latest recorded call per contributor in the curated list, newest first. These are the calls used in the blend.

1 bullish0 bearish0 mixed / exit

  • Laughing Water Capital
    @LaughingH20Cap
    Investment partnership
    Bio & sources
    Bullish+20
    “Grt🧵on $GSK's cancer biz. But IMHO GSK cant max their ROI b/c $ANAB can block GSK from partnering w/ other PD1s like $MRK's Keytruda. Trial is 7/14 & GSK could lose 100% of JEMPERLI which IMHO is ~10% of GSK's mkt cap. I think GSK settles or buys ANAB for big $$. Disc: Long”
    View tweet ↗

Individual calls

Full history in the curated list, newest first. Earlier calls remain visible but do not count toward the blend.

DateContributorInstrumentClaim (verbatim)HorizonScoreSource
2026-06-18Laughing Water Capital
@LaughingH20Cap
Investment partnership
ANAB“Grt🧵on $GSK's cancer biz. But IMHO GSK cant max their ROI b/c $ANAB can block GSK from partnering w/ other PD1s like $MRK's Keytruda. Trial is 7/14 & GSK could lose 100% of JEMPERLI which IMHO is ~10% of GSK's mkt cap. I think GSK settles or buys ANAB for big $$. Disc: Long”—+20Tweet ↗